Pancreatic Cancer Research

ResearcherMedical University of SilesiaActive in the last 2 years

Paweł Lampe

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0862-9666; OpenAlex author ID A5016379728. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 9

  1. The expression of genes KRAS, DPM1, ACRV1, and MBD3L2 in the saliva as potential tumor markers in the detection of pancreatic cancer. Last author DOI 10.5604/01.3001.0055.4390↗
  2. Combination of modified FOLFIRINOX with stereotactic body radiotherapy as an induction therapy for locally advanced pancreatic adenocarcinoma - a prospective s… Co-author DOI 10.5114/wo.2024.137760↗
  3. Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club. Co-author DOI 10.5114/pg.2019.83422↗
  4. Analysis of XRCC2 and XRCC3 gene polymorphisms in pancreatic cancer. Co-author DOI 10.3892/br.2015.550↗
  5. The role of the tissue plasminogen activator as a prognostic and differentiation factor in patients with pancreatic cancer and chronic pancreatitis. Last author PMID 27010898↗
  6. The assessment of serum concentration of adiponectin, leptin and serum carbohydrate antigen-19.9 in patients with pancreatic cancer and chronic pancreatitis. Last author PMID 26579571↗
  7. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis. Co-author DOI 10.1016/j.advms.2014.08.003↗
  8. Concentrations and activities of metalloproteinases 2 and 9 and their inhibitors (TIMPS) in chronic pancreatitis and pancreatic adenocarcinoma. First author PMID 23388475↗
  9. Precursor lesions of early onset pancreatic cancer. Last author DOI 10.1007/s00428-011-1056-3↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daria Dranka-Bojarowska · 5 shared papers, 2012–2025 · strength 0.55
  2. Jakub Ciosek · 1 shared paper, 2025 · strength 0.37
  3. Sławomir Mrowiec · 2 shared papers, 2011–2024 · strength 0.25
  4. Sergiusz Nawrocki · 1 shared paper, 2024 · strength 0.22
  5. Michał Piątek · 1 shared paper, 2024 · strength 0.22
  6. Marek Olakowski · 4 shared papers, 2012–2016 · strength 0.19
  7. Anita Gąsiorowska · 3 shared papers, 2014–2019 · strength 0.19
  8. Renata Talar‐Wojnarowska · 3 shared papers, 2014–2019 · strength 0.19
  9. Ewa I. Malecka-Panas · 3 shared papers, 2014–2019 · strength 0.19
  10. Andrzej Lekstan · 3 shared papers, 2012–2016 · strength 0.14
  11. Beata Jabłońska · 2 shared papers, 2012–2015 · strength 0.08
  12. Katarzyna Winter · 1 shared paper, 2019 · strength 0.08
  13. Stanisław Głuszek · 1 shared paper, 2019 · strength 0.08
  14. Marek Durlik · 1 shared paper, 2019 · strength 0.08
  15. Janusz Strzelczyk · 1 shared paper, 2019 · strength 0.08
  16. A Dâbrowski · 1 shared paper, 2019 · strength 0.08
  17. Beata Smolarz · 1 shared paper, 2016 · strength 0.07
  18. D Baluka · 1 shared paper, 2016 · strength 0.06
  19. Elżbieta Świętochowska · 1 shared paper, 2016 · strength 0.06
  20. Jacek Arkadiusz Śmigielski · 1 shared paper, 2014 · strength 0.04
  21. Łukasz Liszka · 1 shared paper, 2011 · strength 0.03
  22. Edyta Olakowska · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.